Pipeline
Proof of concept to be generated by 5 clinical trials
Indications | Protocol | Location | Preclinical | Clinical Stage | ||
Phase 1 | Phase 2 | Phase 3 | ||||
Brain Metastases | NANORAD 2 100 patients randomized | Recruiting Phase 2 | ||||
NANOBRAINMETS | Recruiting Phase 2 | |||||
Cervical Cancer | NANOCOL | Recruitment completed | ||||
![]() Pancreatic/ | NANOSMART | Recruiting Phase 1 | ||||
![]() Glioblastoma | NANO-GBM | Recruiting Phase 1 |
ODD: Orphan Drug Designation obtained from both the FDA and the EMA

: Phase 2 protocol approved